This opportunity is no longer accepting applications.
grant RFA-DA-25-007

Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)

This grant opportunity aims to support research focusing on two main areas related to HIV and substance use disorder (SUD). Firstly, it seeks to identify targets and pathways to suppress HIV activity in the body, especially in the central nervous system of individuals with SUD. Secondly, it encourages the development of new small molecule drugs that can be used to suppress HIV transcription in…

HIV infection and substance use are comorbid conditions that bidirectionally and synergistically influence the deleterious outcomes in people who suffer from substance use disorders (SUD). The persistence and transcriptional reactivation of HIV lead to the development of neuropathological compl…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Awards & funding

Award Ceiling: $400,000
Award Amount: $400,000

Dates

Opportunity Released: December 20, 2023
Open for Submission: December 20, 2023
Submission Deadline: August 13, 2024
Application Window Closes: August 13, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.